Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'26
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
88.47
262.96
265.89
268.78
348.32
317.85
280.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
88.47
262.96
265.89
268.78
348.32
317.85
280.10
Raw Material Cost
48.33
166.78
181.56
163.74
173.21
144.78
129.17
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
35.34
31.48
31.26
33.93
33.71
29.26
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.01
0.00
0.02
0.01
0.01
0.01
Selling and Distribution Expenses
7.88
36.14
39.90
40.94
49.00
49.77
46.66
Other Expenses
0.28
-2.42
-2.12
-1.84
-1.99
-2.10
-1.80
Total Expenditure (Excl Depreciation)
59.04
214.11
231.73
217.59
236.21
207.30
187.08
Operating Profit (PBDIT) excl Other Income
29.4
48.8
34.2
51.2
112.10000000000001
110.5
93
Other Income
2.50
16.98
24.97
24.31
14.73
23.25
23.11
Operating Profit (PBDIT)
30.47
78.18
71.94
87.95
139.66
144.82
127.33
Interest
0.00
0.01
0.00
0.02
0.01
0.01
0.01
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
40.13
96.18
84.33
105.04
175.11
173.07
150.93
Depreciation
0.00
14.74
14.93
14.77
14.04
12.85
12.52
Profit Before Tax
30.47
63.43
57.01
73.16
125.60
131.96
114.80
Tax
4.10
9.22
6.62
8.80
16.78
17.68
15.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
26.37
54.21
50.39
64.36
108.82
114.28
98.98
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
26.37
54.21
50.39
64.36
108.82
114.28
98.98
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
26.37
54.21
50.39
64.36
108.82
114.28
98.98
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
864.43
836.81
830.53
844.12
858.89
846.22
826.94
Earnings per share (EPS)
0.16
0.34
0.31
0.4
0.68
0.71
0.62
Diluted Earnings per share
0.16
0.34
0.31
0.4
0.68
0.71
0.62
Operating Profit Margin (Excl OI)
31.61%
17.67%
12.05%
18.18%
31.84%
34.21%
32.74%
Gross Profit Margin
34.44%
29.72%
27.06%
32.72%
40.09%
45.56%
45.45%
PAT Margin
29.8%
20.62%
18.95%
23.94%
31.24%
35.95%
35.34%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Analysis not available as Data has been published for only 1 period
Compare Annual Results Of Zhejiang Xinguang Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
88.47
0
88.47
Other Operating Income
0.00
0.00
0.00
Total Operating income
88.47
0
88.47
Raw Material Cost
48.33
0
48.33
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
7.88
0
7.88
Other Expenses
0.28
0.00
0.28
Total Expenditure (Excl Depreciation)
59.04
0
59.04
Operating Profit (PBDIT) excl Other Income
29.43
0.00
29.43
Other Income
2.50
0
2.50
Operating Profit (PBDIT)
30.47
0
30.47
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
40.13
0
40.13
Depreciation
0.00
0
0.00
Profit Before Tax
30.47
0
30.47
Tax
4.10
0
4.10
Provisions and contingencies
0
0
0.00
Profit After Tax
26.37
0
26.37
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
26.37
0
26.37
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
26.37
0
26.37
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
864.43
0
864.43
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
31.61%
0%
0.00
31.61%
Gross Profit Margin
34.44%
0%
0.00
34.44%
PAT Margin
29.80%
0%
0.00
29.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 8.85 Million
in Mar 2026Figures in Million
Annual - Consolidate Net Profit
Consolidate Net Profit 2.64 Million
in Mar 2026Figures in Million
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.80 Million
in Mar 2026Figures in Million
Annual - Interest
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.61%
in Mar 2026Figures in %






